Bolt Biotherapeutics director and Chief Strategy Officer Sheila Gujrathi files initial beneficial ownership statement
BOLT•Director and Chief Strategy Officer Sheila Gujrathi filed an initial beneficial ownership statement dated Oct. 27, 2026.
1. Ownership filing
Sheila Gujrathi, a director and Chief Strategy Officer of Bolt Biotherapeutics, filed an initial beneficial ownership statement dated Oct. 27, 2026.
